Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single‐center, open‐label, prospective randomized study

Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single‐center, open‐label, prospective randomized study

The efficacy and safety of zinc acetate hydrate (ZAH) for zinc supplementation in patients on maintenance hemodialysis (MHD) remains unknown. In this prospective, single‐center, open‐label, parallel‐group trial for MHD patients with serum zinc level

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therapeutic apheresis and dialysis 2020-10, Vol.24 (5), p.568-577
Hauptverfasser: Okamoto, Teppei, Hatakeyama, Shingo, Konishi, Sakae, Okita, Kazutaka, Tanaka, Yoshimi, Imanishi, Kengo, Takashima, Tooru, Saitoh, Fumitada, Suzuki, Tadashi, Ohyama, Chikara
Format: Artikel
Sprache:eng
Schlagworte:
Hematology
hemodialysis
Life Sciences & Biomedicine
polaprezinc
renal anemia
Science & Technology
Urology & Nephrology
zinc acetate hydrate
zinc supplementation
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The efficacy and safety of zinc acetate hydrate (ZAH) for zinc supplementation in patients on maintenance hemodialysis (MHD) remains unknown. In this prospective, single‐center, open‐label, parallel‐group trial for MHD patients with serum zinc level
ISSN:1744-9979
1744-9987
DOI:10.1111/1744-9987.13461